Skip to main content

Animations

MJFF Publications

2311 - 2320 of 8808 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2021
  • 2024
  • 2024
  • 2025
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: Acceptability of digital health technologies in early Parkinson's disease: lessons from WATCH-PD
    Journal Name: Frontiers in Digital Health
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fdgth.2024.1435693
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Evaluation of ATN PD Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000208033
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Nova-ST: Nano-patterned ultra-dense platform for spatial transcriptomics
    Journal Name: Cell Reports Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.crmeth.2024.100831
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Integrative proteomics identifies a conserved Aβ amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer’s disease
    Journal Name: Cell Reports Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.xcrm.2024.101669
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Factors associated with impaired quality of life three months after being diagnosed with COVID-19
    Journal Name: Quality of Life Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s11136-021-02998-9
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Arrayed CRISPR libraries for the genome-wide activation, deletion and silencing of human protein-coding genes
    Journal Name: Nature Biomedical Engineering
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41551-024-01278-4
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Dopaminergic PET to SPECT domain adaptation: a cycle GAN translation approach
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00259-024-06961-x
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Alpha synuclein overexpression can drive microbiome dysbiosis in mice
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-82139-7
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Iron deposition is associated with motor and non-motor network breakdown in parkinsonism
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2024.1518155
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Motor cortical neuronal hyperexcitability associated with α-synuclein aggregation
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00867-z
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.